Prognostic Role of High-Sensitivity Cardiac Troponin T in Patients with Cardiac Sarcoidosis: Insights from ILLUMINATE-CS
In patients with CS, a high hs-cTnT level is a useful predictor of adverse events, and combined measurement of hs-cTnT and BNP further improves the prognostic value.
Authors
- Yuya Matsue (ORCID: https://orcid.org/0000-0003-2456-8525)
- Tatsunori Taniguchi (ORCID: https://orcid.org/0009-0004-3434-5864)
- Hiroaki Kitaoka
- Yoshihisa Naruse (ORCID: https://orcid.org/0000-0001-9630-951X)
- Takeru Nabeta (ORCID: https://orcid.org/0000-0003-4671-7667)
- Yuichi Baba (ORCID: https://orcid.org/0000-0003-2616-0443)
- Takahiro Okumura (ORCID: https://orcid.org/0000-0001-5076-2052)
- Hidekazu Tanaka (ORCID: https://orcid.org/0000-0002-8673-5707)
- Takeshi Kitai (ORCID: https://orcid.org/0000-0003-2416-5865)
- Kenji Yoshioka (ORCID: https://orcid.org/0000-0002-3273-459X)
- Toru Kubo
Institutions
- Hamamatsu University School of Medicine (JP)
- Juntendo University (JP)
- Kochi Medical School Hospital (JP)
- National Cerebral and Cardiovascular Center (JP)
- Kameda Medical Center (JP)
- Nagoya University (JP)
- Kitasato University (JP)
- Kobe University (JP)
- Kōchi University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1002/ehf2.15058
- Citations
- 3
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.98
Funders
- Novartis Pharma